Discussion of MRCTs an “urgent imperative”


The 7th Asian New Drug Development Conference, to be held in Tokyo, Japan from April 15 to 16, will provide a forum for discussion about how MRCT data should be used in new drug applications. Program Chair Dr. Kihito Takahashi, M.D., Ph.D., vice president, Japan Development and Medical Affairs Division, GlaxoSmithKline K.K., said: “As understanding has deepened through experience with these trials, it is an urgent imperative for industry, government and academia to come together to discuss and resolve outstanding issues, and make improvements in collaboration internationally to activate new drug development in Asia.” Find out more.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA